Severe Hypoglycemia Market
                     Severe Hypoglycemia
Presented by- DelveInsight Business Research

What is Severe Hypoglycemia?
The use of glucagon also has the potential to confer economic advantages and to 
free up health care resources by reducing the number of patients who have to be 
admitted to the hospital with severe hypoglycemia.
Currently, various glucagon kits are available in the market as the Glucagon Emergency 
Kit (Eli Lilly) and the GlucaGenHypokit (Novo Nordisk A/S), which can be administered by 
IM or SC injection. 1 mg dose of glucagon (reconstituted in 1 mL of sterile water) is 
recommended for adults and children over 25 kg in weight; half dose (0.5 mL) is 
recommended for children below 25 kg in weight or younger than 6–8 years. If the 
patient does not respond immediately after receiving glucagon, medical help should be 
sought, and IV glucose administered as soon as possible.
In September 2019, GvokeHypoPen (Xeris Pharmaceuticals) was 
approved by the US FDA for the treatment of severe hypoglycemia in 
pediatric and adult patients with diabetes ages 2 years and above. It is 
a ready-to-use, room-temperature-stable, liquid glucagon inside a 
single-use auto-injector pen in 2 pre-measured doses (0.5 mg and 1 mg) 
developed using XeriSol technology.
How Many Regions Are 
Covered?
● The US
● EU5 (Germany, France, Italy, Spain, 
and the United Kingdom)
● Japan
There is currently a lack of 
consensus regarding the threshold 
blood glucose levels that classify 
different stages of hypoglycemia. 
Existing thresholds for defining 
hypoglycemia are based on 
observations from clinical trial 
settings and may not apply to 
everyday practice.
KOL- Views
       To keep up with the market trends, we take KOLs and SME’s opinion working 
in Severe Hypoglycemia domain through primary research to fill the data gaps 
and validate our secondary research. Their opinion helps to understand and 
validate current and emerging therapies treatment patterns or Severe 
Hypoglycemia market trend. This will support the clients in making informed 
business decisions by identifying the overall scenario of the market and the 
unmet needs.
What is the Severe Hypoglycemia 
Report Scope?
● The report covers the descriptive overview of Severe Hypoglycemia , explaining its causes, signs 
and symptoms, pathophysiology, diagnosis and currently available therapies
● Comprehensive insight has been provided into the Severe Hypoglycemia epidemiology and 
treatment in the 7MM
● Additionally, an all-inclusive account of both the current and emerging therapies for Severe 
Hypoglycemia are provided, along with the assessment of new therapies, which will have an 
impact on the current treatment landscape
● A detailed review of Severe Hypoglycemia market; historical and forecasted is included in the 
report, covering drug outreach in the 7MM
● The report provides an edge while developing business strategies, by understanding trends 
shaping and driving the global Severe Hypoglycemia market
What are the Severe 
Hypoglycemia Market Report 
Highlights?
● In the coming years, Severe Hypoglycemia market is set to change due to the rising awareness 
of the disease, and incremental healthcare spending across the world; which would expand the 
size of the market to enable the drug manufacturers to penetrate more into the market
● The companies and academics are working to assess challenges and seek opportunities that 
could influence Severe Hypoglycemia R&D. The therapies under development are focused on 
novel approaches to treat/improve the disease condition       
● Major players are involved in developing therapies for Severe Hypoglycemia . Launch of 
emerging therapies will significantly impact the Severe Hypoglycemia market
● A better understanding of disease pathogenesis will also contribute to the development of novel 
therapeutics for Severe Hypoglycemia
[email protected]
[email protected]
+91-9650213330
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
DFola tYiconu,  aHnda invfoeg rAapnhiycs  Q& uimeagsetsi obyn  or 
Freepik
Query?
Please keep this slide for attribution
Than
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
Flaticon, and infographics & images by 
kFresepik !